Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Venture Funding Deals: CNS Plays Are Attracting Investment

May 13 2019

• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Finance Watch

Related Content

Dyne Launches With $50m For Antibody Conjugates That Deliver Oligonucleotides To Muscles

Apr 03 2019

Finance Watch: Q1 Biopharma Venture Capital Dips From All-Time High, But Numbers Still Impress

Apr 09 2019

AskBio Knocks Down Enough Hurdles To Raise $235m For Its Gene Therapy Platform

Apr 12 2019

Poseida's CAR-T, Gene Therapy Programs Get $142m Boost, Including Novartis Cash

Apr 22 2019

Arrakis Pivots From Platform To Pipeline With $75m For RNA-Targeting Small Molecules

Apr 19 2019

Finance Watch: Hatteras Nearly Halfway To $200m Goal For New Early-Stage VC Fund

Apr 19 2019

Related Companies

Arrakis Therapeutics

Bristol Myers Squibb Company

Asklepios BioPharmaceutical, Inc.

University of North Carolina at Chapel Hill

Baxter International Inc.

Pfizer Inc.

AtaiBeckley N.V.

Aura Biosciences, Inc.

Candel Therapeutics, Inc.

Cullgen Inc.

Aerami Therapeutics

Dyne Therapeutics

CervoMed, Inc.

Vertex Pharmaceuticals Incorporated

Elicio Therapeutics, Inc.

Massachusetts Institute of Technology

Fusion Pharmaceuticals Inc.

Varian Medical Systems, Inc.

Hope Medicine Inc.

Bayer AG

Harmony Biosciences Holdings, Inc.

Polyneuron Pharmaceuticals AG

Poseida Therapeutics, Inc.

Novartis AG

Malin Corp. PLC

SpringWorks Therapeutics Inc.

GSK plc

Synerkine Pharma BV

University Medical Center Utrecht

Talaris Therapeutics, Inc.

Novartis AG

Vividion Therapeutics, Inc.

The Scripps Research Institute (TSRI)

Additional Topics

Financing StartUps and SMEs Deals Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window